COVID-19 vaccines by contract size in doses by country and manufacturer 2021

As of March 9, 2021, India has secured some 2.2 billion COVID-19 vaccine doses through contracts in total. India chose to purchase vaccines manufactured by AstraZeneca (Oxford), Novavax, and the Russian Gamaleya Institute. However, the overwhelming majority of these doses have yet to be produced and delivered. This statistic shows the size of COVID-19 vaccine contracts based on number of doses secured by countries through contracts with manufacturers. The AstraZeneca/Oxford vaccine is by far the most sought COVID-19 vaccine, especially due to its ability to be stored at normal refrigerator temperatures, while other vaccines need ultra cold storage.

截至2021年3月9日，印度已通过合约总计获得约22亿剂COVID-19疫苗。印度选择采购由阿斯利康（牛津）、诺瓦瓦克斯以及俄罗斯加马列亚研究所生产的疫苗。然而，其中绝大多数疫苗尚未生产并交付。此统计数据反映了基于各国通过制造商合约获得的疫苗剂量的COVID-19疫苗合约规模。阿斯利康/牛津疫苗无疑是市面上最受欢迎的COVID-19疫苗，尤其是由于其能够在常规冰箱温度下储存的特性，而其他疫苗则需要超低温储存。